Perspective: Pharmas Looking to Socialytics for Improved Market Intelligence

IDC
April 12, 2012
3 Pages - SKU: IDC3860705
Pharmaceuticals and Healthcare Report - Russia Q4 2104
10/15/2014 | published by: Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further sanctions, the business environment in the country isdeteriorating. As the  |  read more...
USD 1,295
The Office of the Future
10/9/2014 | published by: Frost & Sullivan
The Office of the Future Key Findings The concept, “Office of the Future”, is built on the central idea that the workforce will be increasingly mobile and the work environment itself is  |  read more...
USD 3,500
Priaxon AG - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Priaxon AG - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Priaxon AG - Product Pipeline Review - 2014’, provides an overview of the Priaxon AG’s pharmaceutical research and development focus. This report provides comprehensive information on  |  read more...
USD 1,500
Sealife PHARMA GMBH - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Sealife PHARMA GMBH - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Sealife PHARMA GMBH - Product Pipeline Review - 2014’, provides an overview of the Sealife PHARMA GMBH’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Chroma Therapeutics Ltd. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Chroma Therapeutics Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Chroma Therapeutics Ltd. - Product Pipeline Review - 2014’, provides an overview of the Chroma Therapeutics Ltd.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Conference Documentation: Orphan Drugs and Rare Diseases
10/20/2014 | published by: SMI Publishing, Ltd
Conference Documentation: Orphan Drugs and Rare Diseases SMi are proud to present the 3rd Annual Orphan Drugs and Rare Diseases Conference. The Orphan Drugs market is set to rise  |  read more...
USD 788.78
Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook
10/23/2014 | published by: Timetric
Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook Synopsis Timetric’s 'Chemical & Pharmaceutical Plant Construction in the Philippines to 2018: Market Databook' contains detailed historic and forecast market value data for the chemical  |  read more...
USD 500
Medisyn Technologies, Inc. - Product Pipeline Review - 2014
10/25/2014 | published by: Global Markets Direct
Medisyn Technologies, Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct’s, ‘Medisyn Technologies, Inc. - Product Pipeline Review - 2014’, provides an overview of the Medisyn Technologies, Inc.’s pharmaceutical research and development focus. This report provides  |  read more...
USD 1,500
Iraq Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
Iraq Pharmaceuticals and Healthcare Report Q4 2014 The long-term prospects for the Iraqi pharmaceutical and healthcare markets remain promising given risinghealthcare expenditure as well as further population growth. The Iraqi government has reportedly pledged toinvest USD12bn  |  read more...
USD 1,295
Lithuania Pharmaceuticals and Healthcare Report Q4 2014
10/22/2014 | published by: Business Monitor International
Lithuania Pharmaceuticals and Healthcare Report Q4 2014 BMI View: Collective procurement of medicines with Latvia and Estonia will benefit the development of thepharmaceutical market, albeit at the cost of pricing cuts. While these markets are singularly  |  read more...
USD 1,295
 

SELECT A LICENSE

    Online Download  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!